Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results
Mihir Desai1, Mo Bidair2, Naeem Bhojani3, Andrew Trainer4, Andrew Arther4, Eugene Kramolowsky5, Leo Doumanian1, Dean Elterman6, Ronald P. Kaufman, Jr.7, James Lingeman8, Amy Krambeck8, Gregg Eure9, Gopal Badlani10, Mark Plante11, Edward Uchio12, Greg Gin12, Larry Goldenberg13, Ryan Paterson13, Alan So13, Mitchell R. Humphreys14, Claus G. Roehrborn15, Steven Kaplan16, Jay Motola16, Kevin C. Zorn3
Canadian Journal of Urology, Vol.27, No.2, pp. 10147-10153, 2020
Abstract Introduction: To report 2-year safety and effectiveness of the Aquablation procedure for the treatment of men with symptomatic benign prostatic hyperplasia (BPH) and large-volume 80-150 cc prostates.
Materials and methods: Between September-December 2017, 101 men with moderate-to-severe BPH symptoms and prostate volumes of 80-150 cc underwent an ultrasound-guided robotically executed Aquablation procedure in a prospective multicenter international clinical trial (WATER II). Baseline, procedural and follow-up parameters were recorded at baseline and scheduled postoperative visits. Herein we report 2-year safety and efficacy for this cohort.
Results: Mean prostate volume was 107 cc (range 80-150 cc). Mean IPSS improved from… More >